MULTIPLEX IMMUNO-FLORESCENCE ASSAYS
Learn more about what is happening in the tumor microenvironment of your tissue sample
We are actively implementing measures to protect our employees and customers from COVID-19. Travel restrictions, non-lab essential employee remote work policies, as well as general health procedures are being followed. Our lab remains open and staffed to ensure continuity of service during the pandemic.
Dramatically shorten your drug development timeline + improve chances of success through more informative tissue analysis
Powered by award-winning, proprietary technology and a multidisciplinary team of experts, Flagship Biosciences brings simplicity to a complicated pathology world.
From developing and validating an assay to employing the most comprehensive image analysis data, we provide a full, end-to-end solution for discovering and contextualizing the most relevant endpoints in a CAP/CLIA or RUO setting.
Our approach uses cell-based tissue data, rather than simple pixel data, to provide more accurate information for every sample. Flagship’s unique technology, team, and proven process have reported superior data for hundreds of clinical trials.
Quite simply, we’re changing the drug development paradigm.
Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.
Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.
More accurate and informative tissue data and analytics
Collaboration with our world-renowned scientific team
Increased speed to market for your drug development programs
Enriched clinical diagnostics process for better outcomes